Treatment of Capan-2, a pancreatic cancer cell line with autocrine WNT and HH signaling, with BAY ACC002, suppressed the expression of the WNT/β-catenin target genes AXIN2, BIRC5, MAD2L1 and OCT4 (Figure 2A). This evidence concerns the gene AXIN2 and pancreatic neoplasm.